Literature DB >> 6170682

Biologic properties of chromatographically separated murine thymoma-derived Interleukin 2 and colony-stimulating factor.

M L Hilfiker, R N Moore, J J Farrar.   

Abstract

Two growth factors, interleukin 2 (T cell growth factor) and colony-stimulating factor, are produced concomitantly by a murine EL-4 thymoma cell line after stimulation by phorbol myristate acetate. As shown elsewhere, these thymoma-derived factors appear to be biochemically and functionally indistinguishable from the interleukin 2 and colony-stimulating factor produced by mitogen-stimulated mouse spleen cells. Both factors co-elute during gel filtration with apparent m.w. in the range of 30,000, and both exhibit overlapping isoelectric point profiles between pH 4 and pH 5. Because we were unable to separate these 2 factors by methods based on either m.w. or charge, we have used phenyl-Sepharose chromatography, a method based on hydrophobic interactions, to completely separate murine interleukin 2 and colony-stimulating factor. In contrast with published reports, each of the separated factors exhibits unique biologic activities on lymphocytes and macrophages. Interleukin 2 provides help for antibody synthesis in the nude mouse, but neither enhances interferon production by macrophages nor stimulates macrophage growth. Colony-stimulating factor does not enhance antibody synthesis in the nude mouse but does enhance interferon production by macrophages and stimulate macrophage growth.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6170682

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Granulocyte-macrophage colony-stimulating factor produced by splenic T lymphocytes of mice infected with Schistosoma japonicum.

Authors:  M Owhashi; Y Nawa
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

2.  Specific binding of erythropoietin to spleen cells infected with the anemia strain of Friend virus.

Authors:  S B Krantz; E Goldwasser
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

3.  Multiple hemopoietic lineages are found after stimulation of mouse bone marrow precursor cells with interleukin 3.

Authors:  M B Prystowsky; G Otten; M F Naujokas; J Vardiman; J N Ihle; E Goldwasser; F W Fitch
Journal:  Am J Pathol       Date:  1984-11       Impact factor: 4.307

4.  Interleukin 2 enhances natural killer cell activity through induction of gamma interferon.

Authors:  D A Weigent; G J Stanton; H M Johnson
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

5.  Characterization of soluble factors that induce the cytolytic activity and the expression of T cell growth factor receptors of a T cell hybrid.

Authors:  F Erard; P Corthesy; K A Smith; W Fiers; A Conzelmann; M Nabholz
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

6.  Antigen-independent activation of cytotoxic T cells by lymphokines.

Authors:  L D Williams; W R McMaster; H S Teh
Journal:  Immunology       Date:  1988-05       Impact factor: 7.397

7.  Mouse mammary tumor virus-related sequences in mouse lymphocytes are inducible by 12-O-tetradecanoyl phorbol-13-acetate.

Authors:  B S Kwon; S M Weissman
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

8.  Precipitation of 19S IgM rheumatoid factor-IgG circulating immune complexes in patients with juvenile arthritis by polyethylene glycol and separation by immobilized protein A.

Authors:  T L Moore; R W Dorner; P W Sheridan; J Zuckner
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

9.  Induction of a B-lymphocyte receptor for a T cell-replacing factor by the crosslinking of surface IgD.

Authors:  L J Yaffe; F D Finkelman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

10.  A microassay for colony-stimulating factor based on thymidine incorporation.

Authors:  M B Prystowsky; M F Naujokas; J N Ihle; E Goldwasser; F W Fitch
Journal:  Am J Pathol       Date:  1984-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.